Effects of N-acetylcysteine and glutathione ethyl ester drops on streptozotocin-induced diabetic cataract in rats

Molecular Vision

Volumn 14, Issue , 2008, Pages 862-870

  Zhang, Shu ^a   Chai, Fei Yan ^a   Yan, Hong ^a   Guo, Yong ^a   Harding, J J ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CATALASE; DRUG VEHICLE; EYE DROPS; GLUCOSE; GLUTATHIONE ETHYL ESTER; GLUTATHIONE REDUCTASE; GLYCOSYLATED PROTEIN; SODIUM DIHYDROGEN PHOSPHATE; THIOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CATARACT; CONTROLLED STUDY; DIABETIC CATARACT; DISEASE COURSE; DRUG EFFECT; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; GLUCOSE URINE LEVEL; GLUTATHIONE METABOLISM; LENS; NONHUMAN; PH; PRIORITY JOURNAL; RAT; SLIT LAMP; SPRAGUE DAWLEY RAT; STATISTICAL SIGNIFICANCE; STREPTOZOCIN DIABETES; TREATMENT DURATION;

ACETYLCYSTEINE; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CATALASE; CATARACT; DIABETES MELLITUS, EXPERIMENTAL; EYE PROTEINS; GLUTATHIONE; GLUTATHIONE REDUCTASE; GLYCOSYLATION; INJECTIONS; LENS, CRYSTALLINE; OPHTHALMIC SOLUTIONS; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY; STREPTOZOCIN; SULFHYDRYL COMPOUNDS; WATER;

EID: 44149127234     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Harding JJ. Cataract: biochemistry, epidemiology, and pharmacology. London: Chapman and Hall; 1991.
2. Brian G, Taylor H. Cataract blindness-challenges for the 21st century. Bull World Health Organ 2001; 79:249-56.
3. Harding JJ. Can drugs or micronutrients prevent cataract? Drugs Aging 2001; 18:473-86.
4. Spector A. Review: Oxidative stress and disease. J Ocul Pharmacol Ther 2000; 16:193-201.
5. Wiernsperger NF. Oxidative stress as a therapeutic target in diabetes: revisiting the controversy. Diabetes Metab 2003; 29:579-85.
6. Harding JJ, Blakytny R, Ganea E. Glutathione in disease. Biochem Soc Trans 1996; 24:881-4.
7. Giblin FJ. Glutathione: A vital lens antioxidant. J Ocul Pharmacol Ther 2000; 16:121-35.
8. Ganea E, Harding JJ. Glutathione-related enzymes and the eye. Curr Eye Res 2006; 31:1-11.
9. Ferrer JV, Gasco E, Sastre J, Pallardo FV, Asensi M, Vina J. Age-related changes in glutathione synthesis in the eye lens. Biochem J 1990; 269:531-4.
10. Pau H, Graf P, Sies H. Glutathione levels in human lens: regional distribution in different forms of cataract. Exp Eye Res 1990; 50:17-20.
11. Anderson ME. Glutathione: an overview of biosynthesis and modulation. Chem Biol Interact 1998; 111-112:1-14.
12. Wernerman J, Hammarqvist F. Modulation of endogenous glutathione availability. Curr Opin Clin Nutr Metab Care 1999; 2:487-92.
13. Anderson ME, Powrie F, Puri RN, Meister A. Glutathione monoethyl ester: preparation, uptake by tissues, and conversion to glutathione. Arch Biochem Biophys 1985; 239:538-48.
14. Martensson J, Steinherz R, Jain A, Meister A. Glutathione ester prevents buthionine sulfoximine-induced cataracts and lens epithelial cell damage. Proc Natl Acad Sci USA 1989; 86:8727-31.
15. Kobayashi S, Kasuya M, Shimizu K, Ishii Y, Takehana M, Sakai k, Suzuki N, Itoi M. Glutathione isopropyl ester (YM737) inhibits the progression of X-ray-induced cataract in rats. Curr Eye Res 1993; 12:115-22.
16. Leeuwenburgh C, Ji LL. Glutathione and glutathione ethyl ester supplementation of mice alter glutathione homeostasis during exercise. J Nutr 1998; 128;2420-6.
17. Steenvoorden DP, Hasselbaink DM, Beijersbergen-van-Henegouwen GM. Protection against UV-induced reactive intermediates in human cells and mouse skin by glutathione precursors: a comparison of N-acetylcysteine and glutathione ethyl ester. Photochem Photobiol 1998; 67:651-6.
18. Martensson J, Meister A. Mitochondrial damage in muscle occurs after marked depletion of glutathione and is prevented by giving glutathione monoester. Proc Natl Acad Sci USA 1989; 86:471-5.
19. Jain AK, Lim G, Langford M, Jain SK. Effect of high-glucose levels on protein oxidation in cultured lens cells, and in crystallin and albumin solution and its inhibition by vitamin B6 and N-acetylcysteine: its possible relevance to cataract formation - in diabetes. Free Radic Biol ed 2002; 314:615-21.
20. Neal R, Cooper K, Gurer H, Ercal N. Effects of N-acetylcysteine and 2,3-dimercaptosuccinic acid on lead induced oxidative stress in rat lenses. Toxicology 1998; 130:167-74.
21. Zhao C, Shichi H, Prevention of acetaminophen-induced cataract by a combination of diallyl disulfide and N-acetylcysteine. J Ocul Pharmacol Ther 1998; 14:345-55.
22. Meister A. Glutathione deficiency produced by inhibition of its synthesis and its reversal: applications in research and therapy. Pharmacol Ther 199 1; 51:155-94.
23. Ohtsu A, Kitahara S, Fujii K. Anticataractogenic property of gamma-glutamylcysteine ethyl ester in an animal model of cataract. Ophthalmic Res 1991; 23:51-8.
24. Wan XS, Ware JH, Zhou Z, Donahue JJ, Guan J, Kennedy AR. Protection against radiation-induced oxidative stress in cultured human epithelial cells by treatment with antioxidant agents. Int J Radiat Oncol Biol Phys 2006; 64:1475-81.
25. Seko Y, Pang J, Tokoro T, Ichinose S, Mochizuki M. Blue light-induced apoptosis in cultured retinal pigment epithelium cells of the rat. Graefes Arch Clin Exp: Ophthalmol 2001; 239:47-52.
26. Shattuck. KE, Rassin DK, Grinnell CD. N-acetylcysteine protects from glutathione depletion in rats exposed to hyperoxia. JPEN J Parenter Enteral Nutr 1998; 22:228-33.
27. Lieberman MW, Wiseman AL, Shi ZZ, Shi ZZ, Carter RZ, Barrios R, Ou CN, Chevez-Barrios P, Wang Y, Habib GM, Goodman JC, Huang SL, Lebovitz RM, Matzuk MM. Growth retardation and cysteine deficiency in γ-glutamyl transpeptidasede deficient mice. Proc Natl Acad Sci USA 1996; 93:7923-6.
28. Chevez-Barrios P, Wiseman AL, Rojas E, Ou CN, Lieberman MW. Cataract development in gamma-glutamyl transpeptidase-deficient mice. Exp Eye Res 2000; 71:575-82.
29. Hiraoka T, Clark JI, Thurston GM. Effect of selected anti-cataract agents on pacification in the selenite cataract model. Exp Eye Res 1996; 62:11-9.
30. Suryanarayana P, Saraswat M, Mrudula T, Krishna TP, Krishnaswamy K, Reddy GB. Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats. Invest Ophthalmol Vis Sci 2005; 46:2092-9.
31. Suryanarayana P, Saraswat M, Petrash JM, Reddy GB. Emblica officinalis and its enriched tannoids delay streptozotocin-induced diabetic cataract in rats. Mol Vis 2007; 13:1291-7.
32. Blakytny R, Harding JJ. Prevention of cataract in diabetic rats by aspirin, paracetamol (acetaminophen) and ibuprofen. Exp Eye Res 1992; 54:509-18.
33. Harding JJ. Free and protein-bound glutathione in normal and cataractous human lenses. Biochem J 1970; 117:957-60.
34. Anderson ME. Determination of glutathione and glutathione disulfide in biological samples. Methods Enzymol 1985; 113:548-52.
35. Linetsky MD, Shipova EV, Legrand RD, et al. Glucose-derived Amadori compounds of glutathione. Biochim Biophys Acta. 2005; 1724:181-93.
36. Kilic D. The effects of ageing and sulfur dioxide inhalation exposure on visual-evoked potentials, antioxidant enzyme systems, and lipid-peroxidation levels of the brain and eye. Neurotoxicol Teratol 2003; 25:587-98.
37. Blakytny R, Harding JJ. Glycation (non-enzymic glycosylation) inactivates glutathione reductase. Biochem J 1992; 288:303-7.
38. Ahmed N. Advanced glycation endproducts: role in pathology of diabetic complications. Diabetes Res Chn Pract 2005; 67:3-21.
39. Benrahmoune M, Therond P, Abedinzadeh Z. The reaction of superoxide radical with N-acetylcysteine. Free Radic Biol Med 2000; 29:775-82.
40. Lou MF. Redox regulation in the lens. Prog Retin Eye Res 2003; 22:657-82.
41. Maher P. The effects of stress and aging on glutathione metabolism. Ageing Res Rev 2005; 4:288-314.
42. Reddy VN. Glutathione and its function in the lens: an overview. Exp Eye Res 1990; 50:771-8.
43. Deneke SM, Steiger V, Fanburg BL. Effect of hyperoxia on glutathione levels and glutamic acid uptake in endothelial cells. J Appl Physiol 1987; 63:1966-71.
44. Djurhuus; R, Svardal AM, Thorsen E. Glutathione in the cellular defense of human lung cells exposed to hyperoxia and high pressure. Undersea Hyperb Med 1999; 26:75-85.
45. Nozal MJ, Bernal JL, Toribio L, Marinero P, Moral O, Manzanas L, Rodriguez E. Determination of glutathione, cysteine and N-acetylcysteine in rabbit eye tissues using high-performance liquid chromatography and post-column derivatization with 5,5′-dithiobis(2-nitrobenzoic acid). J Chromatogr A 1997; 778:347-53.
46. Blunt DS, Takemoto L. Inhibition of selenite cataract by S-diethylsuccinyt glutathione isopropyl ester. Curr Eye Res 2000; 20:341-5.
47. Tanito M, Nishiyama A, Tanaka T, Masutani H, Nakamura H, Yodoi J, Ohira A. Change of redox status and modulation by thiol replenishment in retinal photooxidative damage. Invest Ophthalmol Vis Sci 2002; 43:2392-400.
48. Ajiboye R, Harding JJ. The non-enzymic glycosylation of bovine lens proteins by glucosamine and its inhibition by aspirin, ibuprofen and glutathione. Exp Eye Res 1989; 49:31-41.
49. Xie PY, Kanai A, Nakajima A. Glutathione and glutathione-related enzymes in human cataractous lenses. Ophthalmic Res 1991; 23:13340.
50. Bonnefont-Rousselot D, Beaudeux JL, Therond P, Peynet J, Legrand A, Delattre J. Diabetes mellitus, oxidative stress and advanced glycation endproducts. Ann Pharm Fr 2004; 62:147-57.
51. Vlassara H, Palace MR. Diabetes and advanced glycation endproducts. J Intern Med 2002; 251:87-101.